.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Teva
Cantor Fitzgerald
McKinsey
Dow
Covington
Daiichi Sankyo
Argus Health
QuintilesIMS
Cerilliant

Generated: September 26, 2017

DrugPatentWatch Database Preview

Drug Master Files for: ganciclovir

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
15567AII7/31/2001EXCELLA GMBH AND CO KGGANCICLOVIR
16043III7/8/2002RANBAXY LABORATORIES LTDGANCICLOVIR
16992AII11/17/2003EXCELLA GMBH AND CO KGGANCICLOVIR SODIUM
19049AII12/21/2005SUN PHARMACEUTICAL INDUSTRIES LTDGANCICLOVIR (INTERMEDIATE DRUG SUBSTANCE)
19060III12/21/2005SUN PHARMACEUTICAL INDUSTRIES LTDVALGANCICLOVIR HYDROCHLORIDE (NON-STERILE BULK)
28973AII4/2/2015SHANGHAI PHARMA GROUP CHANGZHOU KONY PHARMACEUTICAL CO LTDGANCICLOVIR
23322AII11/30/2009MYLAN LABORATORIES LTDVALGANCICLOVIR HYDROCHLORIDE USP (CRYSTALLINE)
23721AII4/16/2010TRIFARMA SPAGANCICLOVIR, USP
23859AII5/27/2010MYLAN LABORATORIES LTDVALGANCICLOVIR HYDROCHLORIDE USP (AMORPHOUS)
23946AII7/6/2010SUN PHARMACEUTICAL INDUSTRIES LTDVALGANCICLOVIR HYDROCHLORIDE, USP (PROCESS 2; SITE TOANSA)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Merck
Cerilliant
Baxter
Argus Health
Julphar
UBS
Daiichi Sankyo
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot